About
Drug Discovery
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (20)
View allTotal Trials
20
As Lead Sponsor
20
As Collaborator
0
Total Enrollment
3,396
By Phase
PHASE1: 10PHASE1/PHASE2: 1PHASE2: 8PHASE3: 1
By Status
COMPLETED: 15TERMINATED: 3RECRUITING: 2
Clinical Trials Pipeline20 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07110441Lead Sponsor
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
PHASE1Recruiting
52 participants
Started: Aug 26, 2025 · Completed: Dec 31, 2025
NCT05874414Lead Sponsor
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
PHASE1/PHASE2Recruiting
74 participants
Started: Aug 21, 2023 · Completed: Oct 31, 2026
NCT05368935Lead Sponsor
Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects
PHASE1Completed
77 participants
Started: Apr 25, 2022 · Completed: Sep 9, 2022
NCT05116826Lead Sponsor
Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients
PHASE1Completed
25 participants
Started: Nov 5, 2021 · Completed: Apr 13, 2022
NCT04171752Lead Sponsor
Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers
PHASE1Completed
21 participants
Started: Nov 22, 2019 · Completed: Mar 30, 2020
Locations (1)
Headquarters
Loos, France
Map
Loading map...